-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on QuidelOrtho, Raises Price Target to $18

Benzinga·07/08/2026 16:05:52
Listen to the news
Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $13 to $18.